Announcements Trials

Browse Landscape

Phase

Phase 2 81 Phase 1 37 Phase NA 30 Phase 1/2 28 Phase 3 11 Phase EARLY_PHASE1 4 Phase 4 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Neoplasm Metastasis 13 Squamous Cell Carcinoma of Head and Neck 11 Neoplasms 11 Prostatic Neoplasms 10 Breast Neoplasms 9 Recurrence 7 Ovarian Neoplasms 7 Myasthenia Gravis 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Stomach Neoplasms 6 Head and Neck Neoplasms 6 Colorectal Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Fatigue 5 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Melanoma 4 Fallopian Tube Neoplasms 4 Colonic Neoplasms 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Peritoneal Neoplasms 3 Mouth Neoplasms 3 Glioblastoma 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Anorexia 3 Adenocarcinoma Of Esophagus 3

Interventions

Vincristine 1 Rituximab 1 Prednisone 1 Methotrexate 1 Etoposide 1 Cytarabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma × 90 days × Clear all

NCT02405676 2026-03-19

BNHL-2015

Children's Cancer Group, China

Phase 2/3 Active not recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡